Aiforia Technologies logo — Translate images into data, discoveries, and diagnoses with...

Aiforia Technologies

Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis.

Founded 2013 Finland Finland 79 employees Series B Total: $21.15M AI, Biotechnology +5

General Information

Company Name Aiforia Technologies
Founded Year 2013
Location Finland Finland +3
Employees 79
Industries AI, Biotechnology, Education +4
Funding Stage Series B
Social

Get notified when Aiforia Technologies moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Grant Received Jul 31, 2026

Aiforia Technologies has secured €20 million in venture debt financing from the European Investment Bank (EIB), supported by the European Commission’s InvestEU program.

New Partnership Aug 25, 2026

Aiforia Technologies and Stratipath announced a strategic partnership to integrate Stratipath Breast solution into the Aiforia Clinical Platform, providing broader access to AI-powered diagnostic a…

Event Participation Aug 24, 2026

Aiforia Technologies will be participating as an exhibitor at the 38th European Congress of Pathology (ECP) 2026 in Stockholm, Sweden, next month. They will showcase their AI solutions at booth num…

Major Customer Win Aug 18, 2026

Aiforia Technologies published a case study demonstrating how University of Turin utilized Aiforia® Create to build an AI model for mesothelioma subtype recognition.

AI Insight

Bounce Watch AI
2 months ago

Aiforia Technologies is signaling a significant strategic pivot or expansion, highlighted by a substantial website overhaul projected for June 2026. This deep digital transformation, five years post its Series B funding, suggests the company is actively preparing to unveil new offerings, refine its market positioning, or gear up for its next major growth phase. Such a foundational update points towards a strategic realignment and potential future fundraising activities.

Signal Types
Product Update Strategic Planning
Strategic Labels
Digital Transformation Market Repositioning Growth Strategy
Next Move: Fundraising
·
Impact: 7/10
·
Ideal For: Healthtech Growth Equity — Series C/D

About Aiforia Technologies

Aiforia Technologies, founded in 2013, is a cutting-edge company headquartered in Finland. Specializing in deep learning AI for image analysis, they provide advanced software solutions that leverage artificial intelligence to enhance the efficiency and precision of medical image analysis across various disciplines, including oncology and neuroscience.

The company's slogan, "Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis," encapsulates its mission to empower pathologists and researchers. Aiforia aids in the detection of disease biomarkers, accelerates drug development, and refines cancer diagnostics, effectively transforming healthcare from discovery to diagnosis.

In June 2021, Aiforia secured a €12.60M Series B investment led by PHC Holdings. Their focus on AI-driven innovation places them at the forefront of the convergence of biotechnology and healthcare, appealing to investors seeking opportunities in this rapidly evolving space.

Taxonomy: Deep Learning AI, Image Analysis, Digital Pathology, Clinical Diagnostics, Oncology, Neuroscience, Biomarker Identification, R&D Acceleration, Cloud-based Computing, Medical Image Analysis, Virtual Microscopy, SaaS Solutions, Digital Image Management, Pathology Support

Services & Products

Clinical Solutions
Research Solutions
AI Development Tool
Veterinary Solutions

Target Customers

Pathologists Scientists in Clinical Labs Preclinical Researchers Academic Labs Veterinary Diagnostic Labs

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B €12.60M 1 08 Jun 2021
Grant €2.05M 1 20 Sep 2019
Series A €5.00M 3 ACME Investments, Sto-Rahoitus 01 Dec 2017
Seed Round €1.50M 3 Marten Mickos, Jukka Tapaninen 19 Oct 2015

Aiforia Technologies Alternatives & Competitors

Aiforia Technologies vs

Digital Pathology Workflow & AI Solutions

Unknown
42 employees
AI, Biotechnology
Aiforia Technologies vs
HistoWiz
HistoWiz United States

Accelerating scientific research and discoveries through the automation of histology and digital pat...

65 employees
Aiforia Technologies vs

Supporting seamless adaptation in pathology services amidst rapid healthcare changes.

11-50 employees
Health Care

FAQ About Aiforia Technologies

Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis.
Aiforia Technologies was founded in 2013.
Aiforia Technologies is headquartered in Finland.
Aiforia Technologies operates in the following industries: AI, Biotechnology, Education, Health Care, Information Technology, Life Sciences, Machine Learning.
Aiforia Technologies has approximately 79 employees.
Aiforia Technologies has completed 4 funding rounds, raising a total of $21.15M. The latest funding stage is Series B.
Aiforia Technologies offers: Clinical Solutions, Research Solutions, AI Development Tool, Veterinary Solutions.
Top alternatives and competitors to Aiforia Technologies include Virasoft Corporation, HistoWiz, Affiliated Pathologists Medical Group, Deep Bio Inc., Grey Slide Imaging. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aiforia Technologies and Virasoft Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Aiforia Technologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy